About Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
German Cancer Research Center
1
National Center for Tumor Diseases, Heidelberg
1
Clinical Trials at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
During the past decade, Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma
2018-10-19
2024-09-01
Recruiting
60
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie"
#1 collaborator was "German Cancer Research Center" with 1 trials as a collaborator, "Neuro-Oncology Working Group of the German Cancer Society" with 1 trials as a collaborator and "University Hospital Heidelberg" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
According to Clinical.Site data, the most researched conditions in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are
"Glioblastoma" (1 trials), "Glioma" (1 trials), "Malignant Glioma" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
Most popular intervention types in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Placebo" (2 trials), "Avelumab" (1 trials), "IDH1 peptide vaccine" (1 trials) and "IDH1R132H peptide vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
The vast majority of trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie
Currently, there are NaN active trials in "Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".